This website is intended for healthcare professionals only
Specialities

Specialities

Adrenal Disorders
Bone Disorders
Cardiovascular Risk
COVID-19
Diabetes
Endocrine Oncology
General Endocrinology
Kidney Disorders
Obesity
Pediatric Endocrinology
Pituitary Disorders
Reproductive Endocrinology
Thyroid Disorders
Liver Disorders
Rare Disease Day
Search

Trending Topic

Glucose meter device with test strips and lancets on a blue textured background
14 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Clinical outcomes of tirzepatide in a real-world follow-up cohort of patients with type 2 diabetes

Thein M Tun, Muhammad Sabir, Hasanain Alismael

Type 2 diabetes (T2D) is a progressive metabolic condition associated with obesity, cardiovascular disease and substantial morbidity and mortality.1 Despite the availability of multiple glucose-lowering therapies, a significant proportion of individuals with T2D fail to achieve recommended glycemic targets, particularly those with long disease duration, obesity and insulin resistance.2,3 In parallel, excess adiposity remains a major driver of […]

touchREVIEWS in Endocrinology. 2026;22(2):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin
Download html Download html

EUROPEAN ENDOCRINOLOGY VOLUME 13 – ISSUE 2 – AUTUMN 2017

We are delighted to welcome you to the Autumn edition of European Endocrinology, which includes a wide selection of diabetes content to coincide with the EASD 2017.

This edition includes two articles series for you to enjoy. The first explores the development of DPP-4 inhibitors, including vildagliptin, and how the treatment landscape has evolved since research began 25 years ago. The second series focuses on continuous glucose monitoring, and evaluates how it is been adopted within the UK. Further articles on diabetic macular oedema, diabetes pathophysiology and hyperthyroidism are also included for you to enjoy.

We hope you enjoy these articles, along with the multimedia content you will find accompanying many of the articles in this edition.

Thank you to all of our contributing authors. Our Editor-in-Chief Abd Tahrani would like to welcome all members of the endocrinology community to submit articles to our Spring 2018 edition. Visit our submission system if you have a paper to submit.

Select a Section…
1

Foreward

Endo_22.png
General Endocrinology

Foreword – European Endocrinology, 2017;13(2):47

2 mins

Welcome to the autumn edition of European Endocrinology. This issue features topical articles that have been selected for their evaluation of current practices, as well as case studies and research that directly affect endocrinologists and other practitioners involved in the care of patients with endocrine disorders. We begin with three articles that emphasise the importance […]

2

Letter from the Editor-in-Chief

Endo_11.png
General Endocrinology

Call for Submissions 2018

< 1 min

3

Pathogenesis of Type 2 Diabetes

Endo_12.png
Diabetes

Beta-cell Insufficiency

< 1 min

4

Type 2 Diabetes

Endo_7.png
Diabetes

The Vildagliptin Experience – 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration

< 1 min

Endo_21.png
Diabetes

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin – Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes

< 1 min

Endo_22.png
Diabetes

Clinical Safety and Tolerability of Vildagliptin – Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance

< 1 min

5

Continuous Glucose Monitoring

Endo_22.png
Diabetes

Continuous Glucose Monitoring Adoption in the United Kingdom – An Economic and Policy Perspective

< 1 min

Endo_21.png
Diabetes

Is Continuous Glucose Monitoring Underappreciated in the UK?

< 1 min

Endo_10.png
Diabetes

An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in England

< 1 min

6

Cardiovascular Risk

Endo_8.png
Cardiovascular Risk Diabetes

Antihyperglycemic Medications and Cardiovascular Risk Reduction

< 1 min

7

Diabetic Macular Edema

Endo_16.png
Diabetes

Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment

< 1 min

8

Hyperthyroidism

Endo_20.png
Diabetes Thyroid Disorders

Type 2 Diabetes Decompensation as the Clinical Presentation of Thyroid Storm – Cause or Consequence?

< 1 min

3d rendered medically accurate illustration of a mans thyroid gland

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Pragmatic Use of Thyroid Autoantibodies in Clinical Practice: An Update

Naima Parveen, Sachin Chittawar, Deepak Khandelwal

Highlights Autoantibodies refine autoimmune thyroid disorder diagnosis and risk. Thyroid-stimulating hormone receptor antibody predicts relapse, severity and foetal impact. Thyroid peroxidase antibody and thyroglobulin antibody linked to fertility outcomes. Novel antibodies expand thyroid autoimmunity scope. The interplay between immunology and endocrinology is vividly exemplified in autoimmune thyroid disorders (AITDs), where immune dysregulation targets the thyroid gland through both cellular and humoral mechanisms. Hashimoto’s thyroiditis […]

Advertisement
    • 9

    Journal Archive

    View All Issues

    touchREVIEWS in Endocrinology (previously European Endocrinology) is a peer-reviewed, free-to-access, bi-annual journal comprising review articles, case reports, editorials, special reports and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of endocrinology.

    Latest articles videos and clinical updates - straight to your inbox

    Close Popup